Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Monitoring physical and psychosocial symptom trajectories in ovarian cancer patients receiving chemotherapy.

Meraner V, Gamper EM, Grahmann A, Giesinger JM, Wiesbauer P, Sztankay M, Zeimet AG, Sperner-Unterweger B, Holzner B.

BMC Cancer. 2012 Feb 28;12:77. doi: 10.1186/1471-2407-12-77.

2.

Health-related quality of life in early breast cancer.

Groenvold M.

Dan Med Bull. 2010 Sep;57(9):B4184.

PMID:
20816024
3.

Physical distress, emotional status, and quality of life in patients with nasopharyngeal cancer complicated by post-radiotherapy endocrinopathy.

Lue BH, Huang TS, Chen HJ.

Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):28-34. Epub 2007 Aug 31.

PMID:
17765405
4.

Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy.

Greimel E, Kristensen GB, van der Burg ME, Coronado P, Rustin G, del Rio AS, Reed NS, Nordal RR, Coens C, Vergote I; European Organization for Research and Treatment of Cancer - Gynaecological Cancer Group and NCIC Clinical Trials Group..

Gynecol Oncol. 2013 Nov;131(2):437-44. doi: 10.1016/j.ygyno.2013.08.014. Epub 2013 Aug 27.

PMID:
23994107
5.

Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy.

Wedding U, Koch A, Röhrig B, Pientka L, Sauer H, Höffken K, Maurer I.

Acta Oncol. 2008;47(1):56-62.

PMID:
18097778
6.

Malignant ascites symptom cluster in patients referred for paracentesis.

Husain A, Bezjak A, Easson A.

Ann Surg Oncol. 2010 Feb;17(2):461-9. doi: 10.1245/s10434-009-0774-0. Epub 2009 Oct 29.

PMID:
19866240
7.

Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer.

King MT, Stockler MR, Butow P, O'Connell R, Voysey M, Oza AM, Gillies K, Donovan HS, Mercieca-Bebber R, Martyn J, Sjoquist K, Friedlander ML.

Int J Gynecol Cancer. 2014 Jun;24(5):865-73. doi: 10.1097/IGC.0000000000000167.

PMID:
24844220
8.

Fatigue in ovarian carcinoma patients: a neglected issue?

Holzner B, Kemmler G, Meraner V, Maislinger A, Kopp M, Bodner T, Nguyen-Van-Tam D, Zeimet AG, Fleischhacker WW, Sperner-Unterweger B.

Cancer. 2003 Mar 15;97(6):1564-72.

9.

Fatigue, quality of life, and mood states during chemotherapy in Italian cancer patients.

Annunziata MA, Muzzatti B, Mella S, Bidoli E.

Tumori. 2013 Jan-Feb;99(1):e28-33. doi: 10.1700/1248.13808.

PMID:
23549018
10.

Assessing quality of life on the day of chemotherapy administration underestimates patients' true symptom burden.

Giesinger JM, Wintner LM, Zabernigg A, Gamper EM, Oberguggenberger AS, Sztankay MJ, Kemmler G, Holzner B.

BMC Cancer. 2014 Oct 10;14:758. doi: 10.1186/1471-2407-14-758.

11.

Non-cancer life stressors contribute to impaired quality of life in ovarian cancer patients.

Lutgendorf SK, Slavich GM, Degeest K, Goodheart M, Bender D, Thaker PH, Penedo F, Zimmerman B, Lucci J 3rd, Mendez L, Collins K, Sood AK.

Gynecol Oncol. 2013 Dec;131(3):667-73. doi: 10.1016/j.ygyno.2013.09.025. Epub 2013 Oct 3.

12.

Quality of life in ovarian cancer patients receiving chemotherapy.

Lakusta CM, Atkinson MJ, Robinson JW, Nation J, Taenzer PA, Campo MG.

Gynecol Oncol. 2001 Jun;81(3):490-5.

PMID:
11371144
13.

Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.

Fitzsimmons D, Kahl S, Butturini G, van Wyk M, Bornman P, Bassi C, Malfertheiner P, George SL, Johnson CD.

Am J Gastroenterol. 2005 Apr;100(4):918-26.

PMID:
15784041
14.

Changes in quality of life during palliative chemotherapy for solid cancer.

Bang SM, Park SH, Kang HG, Jue JI, Cho IH, Yun YH, Cho EK, Shin DB, Lee JH.

Support Care Cancer. 2005 Jul;13(7):515-21. Epub 2005 Jan 28.

PMID:
15678347
15.

Longitudinal assessment of quality of life in ovarian cancer patients.

Penar-Zadarko B, Binkowska-Bury M, Wolan M, Gawelko J, Urbanski K.

Eur J Oncol Nurs. 2013 Jun;17(3):381-5. doi: 10.1016/j.ejon.2012.10.014. Epub 2012 Nov 29.

PMID:
23200482
16.

Presurgical symptom profiles predict quality of life 2 years after surgery in women with breast cancer.

Chen ML, Liu LN, Miaskowski C, Chen SC, Lin YC, Wang JS.

Support Care Cancer. 2016 Jan;24(1):243-51. doi: 10.1007/s00520-015-2784-8. Epub 2015 May 27.

PMID:
26014617
17.

Prevalence and psychosocial factors of anxiety and depression in breast cancer patients.

Lueboonthavatchai P.

J Med Assoc Thai. 2007 Oct;90(10):2164-74.

PMID:
18041438
18.

Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis.

Clevenger L, Schrepf A, Degeest K, Bender D, Goodheart M, Ahmed A, Dahmoush L, Penedo F, Lucci J 3rd, Thaker PH, Mendez L, Sood AK, Slavich GM, Lutgendorf SK.

Cancer. 2013 Sep 1;119(17):3234-41. doi: 10.1002/cncr.28188. Epub 2013 Jun 24.

19.

Feeling powerless: Locus of control as a potential target for supportive care interventions to increase quality of life and decrease anxiety in ovarian cancer patients.

Brown AJ, Sun CC, Urbauer DL, Bodurka DC, Thaker PH, Ramondetta LM.

Gynecol Oncol. 2015 Aug;138(2):388-93. doi: 10.1016/j.ygyno.2015.05.005. Epub 2015 May 16.

PMID:
25988961
20.

Quality of life across chemotherapy lines in patients with cancers of the pancreas and biliary tract.

Zabernigg A, Giesinger JM, Pall G, Gamper EM, Gattringer K, Wintner LM, Sztankay MJ, Holzner B.

BMC Cancer. 2012 Sep 6;12:390. doi: 10.1186/1471-2407-12-390.

Supplemental Content

Support Center